TY  - GEN
AU  - Dreger,Peter
AU  - Döhner,Hartmut
AU  - Ritgen,Matthias
AU  - Böttcher,Sebastian
AU  - Busch,Raymonde
AU  - Dietrich,Sascha
AU  - Bunjes,Donald
AU  - Cohen,Sandra
AU  - Schubert,Jörg
AU  - Hegenbart,Ute
AU  - Beelen,Dietrich
AU  - Zeis,Matthias
AU  - Stadler,Michael
AU  - Hasenkamp,Justin
AU  - Uharek,Lutz
AU  - Scheid,Christof
AU  - Humpe,Andreas
AU  - Zenz,Thorsten
AU  - Winkler,Dirk
AU  - Hallek,Michael
AU  - Kneba,Michael
AU  - Schmitz,Norbert
AU  - Stilgenbauer,Stephan
TI  - Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
SN  - 1528-0020
PY  - 2010///1123
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Genome
KW  - Germany
KW  - Graft vs Host Disease
KW  - pathology
KW  - Humans
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - diagnosis
KW  - Lymphocyte Transfusion
KW  - Middle Aged
KW  - Neoplasm, Residual
KW  - Prognosis
KW  - Prospective Studies
KW  - Stem Cell Transplantation
KW  - methods
KW  - Transplantation Conditioning
KW  - Transplantation, Homologous
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2010-03-275420
ER  -